More than 30,000 people in British Columbia could be impacted by a recall of the cardiovascular drug valsartan after health officials found an impurity in the drug.
Pharmacare is advising pharmacies to use their standard corporate recall processes to identify and inform patients who currently have a supply of any of the affected lot numbers. Patients are also being requested to replace their existing supply as soon as possible.
According to a press release from the B.C. Pharmacy Association, pharmacists can ensure a patient’s drug therapy is continued by adapting their prescription to another medication in the same classification. Patients where at all possible should visit the pharmacy where the original prescription was filled.
The full health advisory can be found here.
gmckenna@tricitynews.com
